Vigil Neuroscience Inc (NASDAQ:VIGL)’s traded shares stood at 79538.0 during the last session, with the company’s beta value hitting 1.77. At the close of trading, the stock’s price was $3.41, to imply an increase of 6.56% or $0.21 in intraday trading. The VIGL share’s 52-week high remains $11.11, putting it -225.81% down since that peak but still an impressive 25.81% since price per share fell to its 52-week low of $2.53. The company has a valuation of $125.76M, with an average of 0.15 million shares in intraday trading volume over the past 10 days and average of 110.87K shares over the past 3 months.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
After registering a 6.56% upside in the last session, Vigil Neuroscience Inc (VIGL) has traded red over the past five days. The stock hit a weekly high of 3.41, jumping 6.56% in its intraday price action. The 5-day price performance for the stock is 12.17%, and -1.16% over 30 days. With these gigs, the year-to-date price performance is 0.89%. Short interest in Vigil Neuroscience Inc (NASDAQ:VIGL) saw shorts transact 1.04 million shares and set a 12.83 days time to cover.
Vigil Neuroscience Inc (VIGL) estimates and forecasts
Looking at statistics comparing Vigil Neuroscience Inc share performance against respective industry, we note that the company has underperformed competitors. Vigil Neuroscience Inc (VIGL) shares are -47.38% down over the last 6 months, with its year-to-date growth rate lower than industry average at -17.84% against 12.70%. Revenue is forecast to shrink -19.60% this quarter before falling -15.40% for the next one.
VIGL Dividends
Vigil Neuroscience Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Vigil Neuroscience Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Vigil Neuroscience Inc (NASDAQ:VIGL)’s Major holders
Vigil Neuroscience Inc insiders hold 9.33% of total outstanding shares, with institutional holders owning 85.64% of the shares at 94.46% float percentage. In total, 85.64% institutions holds shares in the company, led by Atlas Venture Life Science Advisors, LLC. As of Jun 29, 2023, the company held over 5.84 million shares (or 16.27% of shares), all amounting to roughly $54.87 million.
The next major institution holding the largest number of shares is Northpond Ventures, Llc with 4.21 million shares, or about 11.75% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $39.62 million.
We also have Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Vigil Neuroscience Inc (VIGL) shares. Going by data provided on Jun 29, 2023, Vanguard Total Stock Market Index Fund holds roughly 0.53 million shares. This is just over 1.48% of the total shares, with a market valuation of $5.0 million. Data from the same date shows that the other fund manager holds a little less at 0.32 million, or 0.88% of the shares, all valued at about 1.91 million.
